(Q80401322)
Statements
Pharmacokinetics of gemtuzumab ozogamicin as a single-agent treatment of pediatric patients with refractory or relapsed acute myeloid leukemia (English)
Mary Buckwalter
James A Dowell
Joan Korth-Bradley
Boris Gorovits